HomeIMMX • NASDAQ
add
Immix Biopharma Inc
Previous close
$6.60
Day range
$6.41 - $7.30
Year range
$1.34 - $7.30
Market cap
350.99M USD
Avg Volume
987.86K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.66M | 3.62% |
Net income | -7.59M | -6.10% |
Net profit margin | — | — |
Earnings per share | -0.24 | 0.00% |
EBITDA | -7.57M | -2.38% |
Effective tax rate | -0.10% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.95M | -19.01% |
Total assets | 20.08M | -20.13% |
Total liabilities | 11.82M | 55.66% |
Total equity | 8.26M | — |
Shares outstanding | 33.58M | — |
Price to book | 26.40 | — |
Return on assets | -107.27% | — |
Return on capital | -254.28% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -7.59M | -6.10% |
Cash from operations | -5.91M | -46.32% |
Cash from investing | -372.46K | -37.16% |
Cash from financing | 10.61M | — |
Net change in cash | 4.31M | 200.58% |
Free cash flow | -3.80M | -157.27% |
About
Founded
2012
Headquarters
Website
Employees
18
